Verge Genomics Stock
Verge Genomics operates as a drug discovery company that combines artificial intelligence and neuroscience expertise to find new drugs that would dramatically improve the lives of patients suffering from neurodegenerative disease.
Sign up for SecondMarket™ to view the market and buy or sell Verge Genomics Stock
Buy + SellSee Verge Genomics Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Verge Genomics Stock Valuation + Share Prices
View real-time Tape D™ data on Verge Genomics stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get StartedVerge Genomics Management Team
Chief Scientific Officer
Rob Scannevin
Director
Steve Kanes
Director
Emily Melton
Chief Business Officer
Jane Rhodes
Co-founder, CEO, Director
Alice Zhang
Director
Andrew Allen
Verge Genomics Major Investors
DFJ Venture
IA Ventures
WuXi AppTec
Great Oaks Venture Capital
Section 32
Tao Capital Partners
BlackRock Inc
Eli Lilly & Company
Slow Ventures
Vulcan Capital
Two Sigma Ventures
Merck Global Health Innovation Fund LLC
OS Fund
Threshold Ventures
LifeForce Capital
Karlin Ventures
Agent Capital
ALS Investment Fund
Learn More About Verge Genomics Stock
Buy Verge Genomics Stock
01Verge Genomics stock does not trade on public stock exchanges. Verge Genomics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Verge Genomics stock you can either buy shares directly through company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell Verge Genomics Stock
02Verge Genomics Stock does not trade on public stock exchanges. In order to sell Verge Genomics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Verge Genomics Stock Price
03Verge Genomics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Verge Genomics share price and other valuable private market data.
Read more about secondary market private company stock prices:
Verge Genomics Stock Ticker Symbol
04There is no ticker symbol for Verge Genomics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell Verge Genomics Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Verge Genomics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in Verge Genomics Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Verge Genomics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Verge Genomics Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Verge Genomics IPO
08Verge Genomics is a private company and has not had an IPO. There is currently no Verge Genomics IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Verge Genomics IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket™ to view the market and buy or sell Verge Genomics Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.